Org.nr 998 036 011 2021 → 2022 Year-over-year analysis

4 HEALTH INNOVATION NORGE AS: årsregnskap 2022 vs 2021

Shrank 22% on revenue, returned to profit

approved 2023-06-26; registry 2023-06-29; journal 2023 541533

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2022 with 2021 for 4 HEALTH INNOVATION NORGE AS. Revenue 204.0k NOK → 160.0k NOK (-21.6%). Net result -16.6k NOK → +2.85m NOK. Equity -283.8k NOK → 562.5k NOK.

On the constructive side: operating result improved; turned profitable; equity strengthened. Pressures included: revenue fell.

Also worth watching: book investments changed. All figures are taken from the published annual accounts for 4 HEALTH INNOVATION NORGE AS.

Scorecard

Revenue
204.0k NOK 160.0k NOK
-21.6%
Operating result
-16.6k NOK +1.01m NOK
+6188.7%
Net result
-16.6k NOK +2.85m NOK
+17255.0%
Equity
-283.8k NOK 562.5k NOK
+298.2%
Cash
3 711 NOK 24.3k NOK
+555.8%
Total assets
2.13m NOK 2.85m NOK
+33.8%

What improved

  • ↑

    Operating result improved

    Operating result -16.6k NOK → +1.01m NOK (op. margin -8.1% → 631.4%). Calculated

  • ↑

    Turned profitable

    Net result flipped from a loss of 16.6k NOK to a profit of 2.85m NOK. Calculated

  • ↑

    Equity strengthened

    Book equity -283.8k NOK → 562.5k NOK (equity ratio -13.3% → 19.7%). Calculated

  • ↑

    Cash rose

    Bank deposits 3 711 NOK → 24.3k NOK (+555.8% YoY). Calculated

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 204.0k NOK to 160.0k NOK (-21.6% YoY). Calculated

Things to notice

  • ·

    Book investments changed

    Investment / intangible book value 2 126 NOK → 2.13m NOK. Reported fact